"10.1371_journal.pone.0126959","plos one","2015-05-26T00:00:00Z","Gabriela Ispas; Anil Koul; Johan Verbeeck; Jennifer Sheehan; Brigitte Sanders-Beer; Dirk Roymans; Koen Andries; Marie-Claude Rouan; Sandra De Jonghe; Jean-François Bonfanti; Marc Vanstockem; Kenneth Simmen; Rene Verloes","Janssen Infectious Diseases, Beerse, Belgium; Janssen Research & Development, London, United Kingdom; Huntingdon Life Sciences, 100 Mettlers Road, Somerset, NJ 08873, United States of America; BIOQUAL, Inc., 9600 Medical Center Drive, Rockville, MD 20850, United States of America; Janssen Research & Development, Beerse, Belgium; Jan-Cil France, Janssen Research & Development, Paris, French Republic; Jan-Cil UK, J&J Pharmaceutical Research & Development, High Wycombe, United Kingdom","Conceived and designed the experiments: AK DR KA MCR JFB RV. Performed the experiments: JV JS BSB. Analyzed the data: GI SDJ MV KS. Contributed reagents/materials/analysis tools: JV JS BSB. Wrote the paper: GI AK.","Gabriela Ispas, Anil Koul, Johan Verbeeck, Dirk Roymans, Koen Andries, Marie-Claude Rouan, Jean-François Bonfanti, MarcVanstockem, Kenneth Simmen, Rene Verloes are employees of companies within Janssen Pharmaceutical Companies of J&J, ie: Janssen Infectious Disease, Janssen R&D, Tibotec BVBA, Jan-Cil France, Jan-Cil UK. Anil Koul, Johan Verbeeck, Koen Andries, MarcVanstockem, Kenneth Simmen and Rene Verloes hold stocks in the company. Jennifer Sheehan is employee of Huntington Life Sciences and Brigitte Sanders-Beer is employee of Bioqual. All authors confirm that this does not alter their adherence to all PLOS ONE policies on sharing data and materials.","2015","05","Gabriela Ispas","GI",13,TRUE,6,3,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
